These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The possibility of adverse effect of Kv7-channel opener retigabine on memory processes in rats. Zwierzyńska E; Krupa-Burtnik A; Pietrzak B Epilepsy Behav; 2017 Oct; 75():170-175. PubMed ID: 28866337 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability exposure-response relationship of retigabine (ezogabine) immediate-release tablets in patients with partial-onset seizures. Tompson DJ; Crean CS; Reeve R; Berry NS Clin Ther; 2013 Aug; 35(8):1174-1185.e4. PubMed ID: 23916044 [TBL] [Abstract][Full Text] [Related]
10. The color of skin: blue diseases of the skin, nails, and mucosa. Cohen PR Clin Dermatol; 2019; 37(5):468-486. PubMed ID: 31896403 [TBL] [Abstract][Full Text] [Related]
11. Beneficial Combination of Lacosamide with Retigabine in Experimental Animals: An Isobolographic Analysis. Luszczki JJ; Zagaja M; Miziak B; Kondrat-Wrobel MW; Zaluska K; Wroblewska-Luczka P; Adamczuk P; Czuczwar SJ; Florek-Luszczki M Pharmacology; 2018; 101(1-2):22-28. PubMed ID: 28926841 [TBL] [Abstract][Full Text] [Related]
12. Two cases of oral pigmentation associated with quinidine therapy. Birek C; Main JH Oral Surg Oral Med Oral Pathol; 1988 Jul; 66(1):59-61. PubMed ID: 3165515 [TBL] [Abstract][Full Text] [Related]
13. Mucosal calcified nodule of the hard palate in an infant: case report and review of the literature. Afzal MN; Dancea S; de Nanassy J Pediatr Pathol Lab Med; 1997; 17(4):611-5. PubMed ID: 9211554 [TBL] [Abstract][Full Text] [Related]
14. Palate hyperpigmentation caused by prolonged use of the anti-malarial chloroquine. de Melo Filho MR; da Silva CA; da Rocha Dourado M; de Oliveira Pires MB; Pêgo SP; de Freitas EM Head Neck Pathol; 2012 Mar; 6(1):48-50. PubMed ID: 21877232 [TBL] [Abstract][Full Text] [Related]
15. Solitary mucosal neuroma of the hard palate: a case report. Nishihara K; Yoshida H; Onizawa K; Yusa H; Fujiwara M Br J Oral Maxillofac Surg; 2004 Oct; 42(5):457-9. PubMed ID: 15336775 [TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of an oral mucosal melanoma cell line (MEMO) derived from a longstanding primary oral melanoma. Lourenço SV; Bologna SB; Hsieh R; Sangueza M; Fernandes JD; Nico MM Am J Dermatopathol; 2013 Apr; 35(2):248-51. PubMed ID: 23249835 [TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of ezogabine (retigabine) in adults with refractory partial-onset seizures: Interim results from two ongoing open-label studies. Gil-Nagel A; Brodie MJ; Leroy R; Cyr T; Hall S; Castiglia M; Twomey C; VanLandingham K Epilepsy Res; 2012 Nov; 102(1-2):117-21. PubMed ID: 22771137 [TBL] [Abstract][Full Text] [Related]
19. Effect of a single dose of retigabine in cortical excitability parameters: A cross-over, double-blind placebo-controlled TMS study. Ossemann M; de Fays K; Bihin B; Vandermeeren Y Epilepsy Res; 2016 Oct; 126():78-82. PubMed ID: 27448328 [TBL] [Abstract][Full Text] [Related]
20. P-retigabine: an N-propargyled retigabine with improved brain distribution and enhanced antiepileptic activity. Zhou P; Zhang Y; Xu H; Chen F; Chen X; Li X; Pi X; Wang L; Zhan L; Nan F; Gao Z Mol Pharmacol; 2015 Jan; 87(1):31-8. PubMed ID: 25319542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]